U.S., May 19 -- ClinicalTrials.gov registry received information related to the study (NCT07591740) titled 'Xpert Hemorrhagic Fever on Edge X in Trained and Untrained Users' on May 11.
Brief Summary: A multi-site observation study that was conducted in the United States at 3 CLIA Waived sites with Untrained Users testing on Xpert Hemorrhagic fever tests on Edge X instruments
Study Start Date: Oct. 21, 2024
Study Type: OBSERVATIONAL
Condition:
Hemorrhagic Fever
Intervention:
DIAGNOSTIC_TEST: Xpert Hemorrhagic Fever test
Detection and identification of RNA from multiple viruses in CWB and VWB from individuals with signs and symptoms of the suspected infections and/or individuals who are at risk for exposure or may have been exposed to...